8-K: Cannabist Company Initiates Restructuring, Sells Ohio & Delaware Assets

The Cannabist Company Holdings Inc. has commenced CCAA proceedings and entered into definitive agreements to sell its Ohio and Delaware cannabis operations for a combined $63.5 million, while also planning to wind down operations in New York and Pennsylvania.

Summary

• The Cannabist Company Holdings Inc. (formerly Columbia Care) has initiated voluntary proceedings under Canada's Companies Creditors Arrangement Act (CCAA) and intends to seek Chapter 15 recognition in the U.S.
• This comprehensive restructuring process is supported by senior secured noteholders, representing approximately 60% of outstanding notes.
• A definitive agreement has been signed to sell its Ohio cannabis operations to Holistic Industries Inc. for a total consideration of $47 million, consisting of $34.5 million in cash and a $12.5 million promissory note. This transaction is expected to close in Q3 2026.
• A separate definitive agreement has been entered into with Parma Holdco LLC to sell its Delaware cannabis assets for a total consideration of $16.5 million in cash, with $2.475 million held in escrow for indemnification. This transaction is expected to close in Q2 2026.
• A non-binding memorandum of understanding is in place for the sale of operations in Colorado, Illinois, Massachusetts, Maryland, New Jersey, and West Virginia, aiming for at least $25 million in cash plus a $25 million note.
• The company has begun an orderly cessation of operations in New York and Pennsylvania, with no rent or payroll expenses to be incurred in these states after April 30, 2026.
• FTI Consulting Canada Inc. has been appointed as monitor for the CCAA proceedings, and SierraConstellation Partners LLC as Chief Restructuring Officer.
• Trading of the company's shares on Cboe Canada Inc. is anticipated to be halted and the company will be subject to a delisting review.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a highly negative development, as the company is undergoing formal restructuring proceedings and divesting core assets, indicating severe financial distress and an uncertain future for existing shareholders.

Positives

• Secured definitive agreements for the sale of Ohio and Delaware cannabis operations, totaling $63.5 million, providing significant liquidity.
• Obtained support from senior secured noteholders (over 60% of outstanding notes) for the restructuring and sale process, indicating a coordinated effort to address financial challenges.
• Entered into a non-binding memorandum of understanding for the sale of operations in six additional states, signaling further asset monetization and a clear strategic direction.
• Appointed a Chief Restructuring Officer and a monitor to oversee the CCAA proceedings, aiming for an orderly and supervised process.

Negatives

• Initiation of voluntary proceedings under the Companies Creditors Arrangement Act (CCAA) in Canada and planned Chapter 15 proceedings in the U.S., which are typically last-resort measures for financially distressed entities.
• Anticipated halt in trading of shares on Cboe Canada Inc. and subjection to a delisting review, indicating severe impact on shareholder value and market access.
• Cessation of operations in New York and Pennsylvania, leading to a reduction in market presence and potential write-offs.
• The strategic review process was initiated due to "persistent operational and financial challenges" facing the company and the broader industry, confirming a difficult financial situation.
• The Ohio transaction includes a $12.5 million promissory note, not immediate cash, and is subject to a performance covenant that could reduce the purchase price based on revenue declines.
• The Delaware transaction includes $2.475 million held in escrow for indemnification, delaying full cash receipt and exposing the company to potential future liabilities.

Risks

• The company's ability to successfully complete the sale process under the Restructuring Proceedings or any of the other disclosed transactions, or to sell any of its remaining businesses or assets.
• Potential adverse effects of the Restructuring Proceedings on the company's liquidity and results of operations.
• The company's ability to obtain timely approval by the applicable courts with respect to the motions filed in the Restructuring Proceedings.
• Objections to the company's sale process or other pleadings filed that could protract the Restructuring Proceedings.
• Employee attrition and the company's ability to retain senior management and other key personnel due to the distractions and uncertainties, including the company's ability to provide adequate compensation and benefits during Restructuring Proceedings.
• The company's ability to comply with the restrictions imposed by its financing arrangements.
• The company's ability to maintain relationships with suppliers, customers, employees and other third parties and regulatory authorities as a result of the Restructuring Proceedings.
• The applicable rulings in the Restructuring Proceedings and the outcome of the Restructuring Proceedings generally.
• The length of time that the company will operate under CCAA and Chapter 15 protection and the continued availability of operating capital during the pendency of the proceedings.
• Risks associated with third-party motions in the Restructuring Proceedings, which may interfere with the company's ability to consummate any sale of its business or assets.
• Increased administrative and legal costs related to the Restructuring Proceedings and other litigation and inherent risks involved in a bankruptcy process.
• Risks related to U.S. federal cannabis laws, which classify marijuana as a Schedule I controlled substance, potentially leading to civil forfeiture of assets or criminal penalties despite state-level legalization.
• The Ohio transaction's purchase price is subject to a performance covenant based on revenue, which could lead to a reduction if monthly net revenue decreases by 15% or more for two consecutive months, or if average monthly net revenue decreases by 17.5% or more relative to January Monthly Net Revenue.

Future Outlook

The company expects to complete the Ohio transaction in Q3 2026 and the Delaware transaction in Q2 2026. It also intends to finalize definitive documentation for the sale of operations in six other states. The CCAA and Chapter 15 proceedings are aimed at supporting these transactions, preserving liquidity, and facilitating an orderly wind-down of non-core operations. Trading of shares on Cboe Canada Inc. is anticipated to be halted and subject to delisting review.

Management Comments

• "The Strategic Transactions, and the CCAA Proceedings necessary to implement such transactions, are the best option available for The Cannabist Company and its stakeholders."
• "The Company has commenced CCAA Proceedings to support the completion of the Strategic Transactions and the pursuit of the Remaining Markets Transaction, as well as to preserve liquidity and facilitate an orderly wind-down of operations in markets not subject to the Strategic Transactions or the Remaining Markets Transaction, including New York and Pennsylvania."

Industry Context

StockSavvy.ai notes that the cannabis industry in the U.S. continues to face significant operational and financial challenges, exacerbated by the conflict between state-level legalization and federal prohibition. The Cannabist Company's comprehensive restructuring and asset divestiture strategy reflects a broader trend of consolidation and rationalization among multi-state operators (MSOs) seeking to optimize their portfolios and improve financial health amidst a complex regulatory and capital market environment. The focus on divesting non-core assets and streamlining operations is a common response to persistent profitability pressures and limited access to traditional financing.

Comparison to Industry Standards

• The company's initiation of CCAA and Chapter 15 proceedings is a severe measure, typically indicative of significant financial distress, and is not a standard operational practice for healthy companies in the cannabis industry or any other sector.
• The asset sale prices of $16.5 million for Delaware and $47 million for Ohio, while providing liquidity, should be assessed against the company's historical investments and market valuations of comparable cannabis assets, which have generally seen downward pressure in recent years due to industry headwinds.
• The previous Virginia transaction for $130 million, which closed in February 2026, provided substantial capital, but the current filings suggest that this was insufficient to resolve the company's broader financial challenges, necessitating further divestitures and restructuring.
• The inclusion of a promissory note ($12.5 million in Ohio) and escrowed funds ($2.475 million in Delaware) as part of the consideration indicates a buyer's market and a need for sellers to accept structured payments, which is common in distressed asset sales but less favorable than all-cash deals.
• The performance covenant in the Ohio deal, allowing for purchase price reduction based on revenue declines, places additional risk on the seller, reflecting buyer caution in a volatile market.

Management Changes

Corporate Governance

Legal Proceedings

• Commencement of voluntary proceedings under the Companies Creditors Arrangement Act (Canada) (CCAA) in the Ontario Superior Court of Justice (Commercial List) on March 24, 2026.
• Initial order obtained in CCAA Proceedings, providing a 10-day stay of proceedings (with potential extensions) and appointing FTI Consulting Canada Inc. as monitor.
• Intention to commence proceedings under Chapter 15 of the U.S. Bankruptcy Code in the District of Delaware to seek recognition of the CCAA Proceedings.
• The Ohio Equity Purchase Agreement mentions an 'Antitrust Claim' (State of Ohio ex rel. Dave Yost, Attorney General of Ohio v. Ascend Wellness Holdings, Inc., et al., Case No.: 26 CV 001146) which is an Excluded Liability for the buyer, indicating ongoing or potential litigation related to past business practices.

Related Party Transactions

• The Delaware Asset Purchase Agreement involves Parma Holdco LLC, an affiliate of a Boston-based SEC-registered investment fund with a portfolio of investment in the US cannabis industry. Parma was also the buyer in the previously announced Virginia Transaction.
• Millstreet Credit Fund LP is a party to the Delaware Asset Purchase Agreement, indirectly owning or controlling $33,153,000.00 of the company's Notes, and guarantees Buyer's payment obligations under the Delaware agreement.

Stakeholder Impact

• Shareholders: Highly negative impact due to anticipated trading halt, delisting review, and the comprehensive restructuring process which often results in significant dilution or loss of equity value.
• Noteholders: Supporting Noteholders (holding approximately 60% of notes) have agreed to support the restructuring, indicating a path to recovery, but the process involves asset sales and potential for partial repayment or new debt instruments. Their claims are senior to equity.
• Employees: Operations in New York and Pennsylvania are ceasing, leading to job losses. Employees in divested operations will transition to new employers (Holistic, Parma), with offers of comparable compensation and benefits. A Chief Restructuring Officer has been appointed, which can signal further workforce adjustments.
• Customers: Operations in New York and Pennsylvania will cease, impacting customer access. Customers in Ohio and Delaware will see a change in ownership and potentially brands/products.
• Suppliers/Creditors: The CCAA proceedings provide a stay of proceedings, impacting creditors' ability to enforce claims. The restructuring aims to manage liabilities, but some creditors may face delayed or reduced payments.

Next Steps

• Complete the sale of Ohio operations to Holistic Industries Inc. (expected Q3 2026).
• Complete the sale of Delaware assets to Parma Holdco LLC (expected Q2 2026).
• Finalize definitive documentation for the sale of operations in Colorado, Illinois, Massachusetts, Maryland, New Jersey, and West Virginia.
• Continue orderly cessation of operations in New York and Pennsylvania.
• Seek recognition of CCAA Proceedings in the U.S. Bankruptcy Court for the District of Delaware (Chapter 15 Proceedings).
• Obtain Canadian Court approval (Sale Order) for the transactions.
• Address anticipated trading halt and delisting review on Cboe Canada Inc.
• Implement the comprehensive restructuring and sale process in accordance with specified milestones, court approvals, and reporting obligations.
• Negotiate in good faith to resolve any legal, regulatory, or structural impediments to the Restructuring Process.
• Prepare and timely file all Tax Returns related to the Companies for Pre-Closing Tax Periods.
• Buyer to arrange for substitute letters of credit, guarantees, and other obligations to replace Seller Guarantees.

Key Dates

Recommendation

The initiation of CCAA and Chapter 15 bankruptcy proceedings, coupled with the divestiture of significant assets and the cessation of operations in key markets, signals severe financial distress and a high probability of substantial value impairment for existing equity holders. The anticipated trading halt and delisting review further underscore the dire outlook. While asset sales provide some liquidity, the overall restructuring process is designed to address overwhelming liabilities, likely leaving little to no recovery for common shareholders.

Keywords

Cannabis, Restructuring, Asset Sale, SEC Filing, 8-K, CCAA, Chapter 15, Ohio, Delaware, Holistic Industries, Parma Holdco, Marijuana, Multi-State Operator, Distressed Assets, Bankruptcy, Delisting